![Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR) Teva-Aripiprazole Tablets for the treatment of Schizophrenia Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR) Teva-Aripiprazole Tablets for the treatment of Schizophrenia](https://mma.prnewswire.com/media/740717/Teva_Canada_Limited_Teva_Canada_Announces_the_Launch_of_a_Generi.jpg?p=twitter)
Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR) Teva-Aripiprazole Tablets for the treatment of Schizophrenia
![Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR) Teva-Aripiprazole Tablets for the treatment of Schizophrenia Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR) Teva-Aripiprazole Tablets for the treatment of Schizophrenia](https://mma.prnewswire.com/media/740720/Teva_Canada_Limited_Teva_Canada_Announces_the_Launch_of_a_Generi.jpg?p=facebook)
Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR) Teva-Aripiprazole Tablets for the treatment of Schizophrenia
Aripiprazole Teva bruges til at behandle voksne og unge i alderen 13 år og ældre, som lider af en sygdom, der er forbundet med
1 Sp. zn. sukls132087/2022 Příbalová informace: informace pro uživatele Aripiprazole Teva 10 mg tablety Aripiprazole Teva 15
PRODUCT MONOGRAPH Pr TEVA-ARIPIPRAZOLE Aripiprazole Tablets, USP 2 mg, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg Antipsychotic agent T
![Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | SpringerLink Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-020-01566-w/MediaObjects/12325_2020_1566_Figa_HTML.png)